REMEDIUM LIFECARE (India) Today

REMEDIUM LIFECARE is trading at 126.80 as of the 26th of September 2021, a -0.63 percent down since the beginning of the trading day. The stock's lowest day price was 125.75. Equity ratings for REMEDIUM LIFECARE LIMITED are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of August 2021 and ending today, the 26th of September 2021. Click here to learn more.

REMEDIUM LIFECARE Stock Profile

REMEDIUM LIFECARE is not yet fully synchronised with the market data
REMEDIUM LIFECARE is way too risky over 90 days horizon
REMEDIUM LIFECARE appears to be risky and price may revert if volatility continues
Legal NameREMEDIUM LIFECARE LIMITED
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of REMEDIUM LIFECARE's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedOvervalued
REMEDIUM LIFECARE LIMITED (REMLIFE) is traded on Bombay Stock Exchange in India .
Check REMEDIUM LIFECARE Probability Of Bankruptcy

REMEDIUM Stock Price Odds Analysis

What are REMEDIUM LIFECARE's target price odds to finish over the current price? Based on a normal probability distribution, the odds of REMEDIUM LIFECARE jumping above the current price in 90 days from now is about 31.18%. The REMEDIUM LIFECARE LIMITED probability density function shows the probability of REMEDIUM LIFECARE stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon REMEDIUM LIFECARE LIMITED has a beta of -0.5107 indicating as returns on benchmark increase, returns on holding REMEDIUM LIFECARE are expected to decrease at a much lower rate. During the bear market, however, REMEDIUM LIFECARE LIMITED is likely to outperform the market. In addition to that, the company has an alpha of 3.3827, implying that it can generate a 3.38 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 126.8HorizonTargetOdds Up 126.8 
68.72%90 days
 126.80 
31.18%
Based on a normal probability distribution, the odds of REMEDIUM LIFECARE to move above the current price in 90 days from now is about 31.18 (This REMEDIUM LIFECARE LIMITED probability density function shows the probability of REMEDIUM Stock to fall within a particular range of prices over 90 days) .

REMEDIUM LIFECARE Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. REMEDIUM LIFECARE market risk premium is the additional return an investor will receive from holding REMEDIUM LIFECARE long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in REMEDIUM LIFECARE. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although REMEDIUM LIFECARE's alpha and beta are two of the key measurements used to evaluate REMEDIUM LIFECARE's performance over the market, the standard measures of volatility play an important role as well.

REMEDIUM Stock Against Markets

Picking the right benchmark for REMEDIUM LIFECARE stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in REMEDIUM LIFECARE stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for REMEDIUM LIFECARE is critical whether you are bullish or bearish towards REMEDIUM LIFECARE LIMITED at a given time.

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with REMEDIUM LIFECARE stock to make a market-neutral strategy. Peer analysis of REMEDIUM LIFECARE could also be used in its relative valuation, which is a method of valuing REMEDIUM LIFECARE by comparing valuation metrics with similar companies.
Additionally, take a look at Your Equity Center. Note that the REMEDIUM LIFECARE information on this page should be used as a complementary analysis to other REMEDIUM LIFECARE's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.

Other Tools for REMEDIUM Stock

When running REMEDIUM LIFECARE price analysis, check to measure REMEDIUM LIFECARE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy REMEDIUM LIFECARE is operating at the current time. Most of REMEDIUM LIFECARE's value examination focuses on studying past and present price action to predict the probability of REMEDIUM LIFECARE's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move REMEDIUM LIFECARE's price. Additionally, you may evaluate how the addition of REMEDIUM LIFECARE to your portfolios can decrease your overall portfolio volatility.
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go